The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

Nils Koch-Henriksen; Per Soelberg Sørensen; Klaus Bendtzen; Esben Meulengracht Flachs

doi:10.1177/1352458508101946

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

Nils Koch-Henriksen
, Per Soelberg Sørensen
, Klaus Bendtzen
, Esben Meulengracht Flachs

The Faculty of Health Sciences

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Multiple sclerosis
Volume	15
Issue number	5
Pages (from-to)	601-605
ISSN	1352-4585
DOIs	https://doi.org/10.1177/1352458508101946
Publication status	Published - 2009

Documents & Links

10.1177/1352458508101946

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{ddfc2240004b11dfaefb000ea68e967b,

title = "The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.",

author = "Nils Koch-Henriksen and S{\o}rensen, \{Per Soelberg\} and Klaus Bendtzen and Flachs, \{Esben Meulengracht\}",

year = "2009",

doi = "10.1177/1352458508101946",

language = "English",

volume = "15",

pages = "601--605",

journal = "Multiple sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "5",

}

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis. / Koch-Henriksen, Nils; Sørensen, Per Soelberg; Bendtzen, Klaus et al.
In: Multiple sclerosis, Vol. 15, No. 5, 2009, p. 601-605.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

AU - Koch-Henriksen, Nils

AU - Sørensen, Per Soelberg

AU - Bendtzen, Klaus

AU - Flachs, Esben Meulengracht

PY - 2009

Y1 - 2009

U2 - 10.1177/1352458508101946

DO - 10.1177/1352458508101946

M3 - Journal article

SN - 1352-4585

VL - 15

SP - 601

EP - 605

JO - Multiple sclerosis

JF - Multiple sclerosis

IS - 5

ER -